Cargando…

Hirudo (Leech) for proliferative vitreous retinopathy: A protocol for systemic review and meta-analysis

INTRODUCTION: Proliferative vitreous retinopathy (PVR) is characterized by proliferation of cells and contraction of membranes on either the retinal surface or in the vitreous cavity, which leads to retinal detachment and visual impairment. PVR is commonly seen in patients with rhegmatogenous retina...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hui, Lei, Ruxue, Li, Yuanyuan, Huang, Qun, Gao, Na, Zou, Weiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837824/
https://www.ncbi.nlm.nih.gov/pubmed/33546086
http://dx.doi.org/10.1097/MD.0000000000024412
_version_ 1783643031537188864
author Huang, Hui
Lei, Ruxue
Li, Yuanyuan
Huang, Qun
Gao, Na
Zou, Weiwen
author_facet Huang, Hui
Lei, Ruxue
Li, Yuanyuan
Huang, Qun
Gao, Na
Zou, Weiwen
author_sort Huang, Hui
collection PubMed
description INTRODUCTION: Proliferative vitreous retinopathy (PVR) is characterized by proliferation of cells and contraction of membranes on either the retinal surface or in the vitreous cavity, which leads to retinal detachment and visual impairment. PVR is commonly seen in patients with rhegmatogenous retinal detachment and diabetic retinopathy, which seriously affects the patient's work and life. Previous studies indicated that Hirudo (Leech) or compound prescription containing Hirudo (Leech) for treatment of PVR would be effective. However, due to the lack of evidence, there are no specific methods or suggestions, so it is necessary to carry out systematic evaluations on Hirudo (Leech) for PVR and provide effective evidence for further research. METHODS AND ANALYSIS: The following 8 databases will be searched: Cochrane Central Register of Controlled Trials, PubMed, MEDLINE, EMBASE, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, VIP Database, and Wanfang Database. All randomized controlled trials in English or Chinese related to Hirudo (Leech) for PVR will be included. Outcomes will include change in Vitreous opacity, Vision changes, production of the anterior macular membrane, and retinal detachment again. The incidence of adverse events will be assessed for safety evaluation. Study inclusion, data extraction and quality assessment will be performed independently by 2 reviewers. Assessment of risk of bias and data synthesis will be performed using Review Manager V.5.3. RESULTS: In this systematic review and meta-analysis, we will synthesize the studies to assess the safety and efficacy of Hirudo (Leech) for PVR. CONCLUSION: The summary of our study will clarify whether Hirudo (Leech) therapy could be an efficient and safe method for PVR, which can further guide the promotion and application of it. OPEN SCIENCE FRAMEWORK (OSF) REGISTRATION NUMBER: 10.17605/OSF.IO/FP7VG (https://osf.io/fp7vg)
format Online
Article
Text
id pubmed-7837824
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-78378242021-01-27 Hirudo (Leech) for proliferative vitreous retinopathy: A protocol for systemic review and meta-analysis Huang, Hui Lei, Ruxue Li, Yuanyuan Huang, Qun Gao, Na Zou, Weiwen Medicine (Baltimore) 5800 INTRODUCTION: Proliferative vitreous retinopathy (PVR) is characterized by proliferation of cells and contraction of membranes on either the retinal surface or in the vitreous cavity, which leads to retinal detachment and visual impairment. PVR is commonly seen in patients with rhegmatogenous retinal detachment and diabetic retinopathy, which seriously affects the patient's work and life. Previous studies indicated that Hirudo (Leech) or compound prescription containing Hirudo (Leech) for treatment of PVR would be effective. However, due to the lack of evidence, there are no specific methods or suggestions, so it is necessary to carry out systematic evaluations on Hirudo (Leech) for PVR and provide effective evidence for further research. METHODS AND ANALYSIS: The following 8 databases will be searched: Cochrane Central Register of Controlled Trials, PubMed, MEDLINE, EMBASE, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, VIP Database, and Wanfang Database. All randomized controlled trials in English or Chinese related to Hirudo (Leech) for PVR will be included. Outcomes will include change in Vitreous opacity, Vision changes, production of the anterior macular membrane, and retinal detachment again. The incidence of adverse events will be assessed for safety evaluation. Study inclusion, data extraction and quality assessment will be performed independently by 2 reviewers. Assessment of risk of bias and data synthesis will be performed using Review Manager V.5.3. RESULTS: In this systematic review and meta-analysis, we will synthesize the studies to assess the safety and efficacy of Hirudo (Leech) for PVR. CONCLUSION: The summary of our study will clarify whether Hirudo (Leech) therapy could be an efficient and safe method for PVR, which can further guide the promotion and application of it. OPEN SCIENCE FRAMEWORK (OSF) REGISTRATION NUMBER: 10.17605/OSF.IO/FP7VG (https://osf.io/fp7vg) Lippincott Williams & Wilkins 2021-01-22 /pmc/articles/PMC7837824/ /pubmed/33546086 http://dx.doi.org/10.1097/MD.0000000000024412 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5800
Huang, Hui
Lei, Ruxue
Li, Yuanyuan
Huang, Qun
Gao, Na
Zou, Weiwen
Hirudo (Leech) for proliferative vitreous retinopathy: A protocol for systemic review and meta-analysis
title Hirudo (Leech) for proliferative vitreous retinopathy: A protocol for systemic review and meta-analysis
title_full Hirudo (Leech) for proliferative vitreous retinopathy: A protocol for systemic review and meta-analysis
title_fullStr Hirudo (Leech) for proliferative vitreous retinopathy: A protocol for systemic review and meta-analysis
title_full_unstemmed Hirudo (Leech) for proliferative vitreous retinopathy: A protocol for systemic review and meta-analysis
title_short Hirudo (Leech) for proliferative vitreous retinopathy: A protocol for systemic review and meta-analysis
title_sort hirudo (leech) for proliferative vitreous retinopathy: a protocol for systemic review and meta-analysis
topic 5800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837824/
https://www.ncbi.nlm.nih.gov/pubmed/33546086
http://dx.doi.org/10.1097/MD.0000000000024412
work_keys_str_mv AT huanghui hirudoleechforproliferativevitreousretinopathyaprotocolforsystemicreviewandmetaanalysis
AT leiruxue hirudoleechforproliferativevitreousretinopathyaprotocolforsystemicreviewandmetaanalysis
AT liyuanyuan hirudoleechforproliferativevitreousretinopathyaprotocolforsystemicreviewandmetaanalysis
AT huangqun hirudoleechforproliferativevitreousretinopathyaprotocolforsystemicreviewandmetaanalysis
AT gaona hirudoleechforproliferativevitreousretinopathyaprotocolforsystemicreviewandmetaanalysis
AT zouweiwen hirudoleechforproliferativevitreousretinopathyaprotocolforsystemicreviewandmetaanalysis